Reading time is 1 mins
.
.
NEW DEVELOPMENTS FOR THE ‘ MADE IN TURKEY ‘ VACCINES
In scientific cooperation with the Turkish Health Institutes presidency (TÜSEB) and Erciyes University (ERU) Vaccine Research and Development Center (ERAGEM), voluntary applications for Phase-3 studies of the domestic vaccine developed against the corona virus in Turkey began via e-Pulse.
* A Phase-1 Study of the Covid-19 native vaccine developed by TÜSEB and ERAGEM against coronavirus was conducted on 44 volunteers.
* Phase-2 studies of the inactive vaccine began in February, and 250 volunteers completed the vaccine on April 9. At the end of April, Phase-2 reporting was completed.
* In the reporting, it was determined that 100 percent of the volunteers who received the corona virus vaccine had antibodies. Then, in May, Phase-3 work began.
* In this context, voluntary recruitment via e-Pulse was started. On his E-pulse page, he said, “volunteer for the vaccine study. Click here to volunteer in Phase-3 clinical trials of the inactive Covid-19 vaccine developed in cooperation with the Turkish Health Institutes and Erciyes University.”
.
CALL FOR ‘VOLUNTEERING’ FOR PHASE-3 IN DOMESTIC VACCINE
Applications for those who want to volunteer in the Phase-3 study of the Covid-19 vaccine developed by Erciyes University have begun to be received. The Turkish Health Minister called for voluntary phase-3 via e-Pulse.
Among the domestic vaccines developed against the corona virus in Turkey, human experiments were first started and Phase-1 and Phase-2 phase were completed in the Covid-19 Vaccine of Erciyes University, which reached Phase-3. The Department of Health has opened a ‘volunteer’ button on the E-Pulse app for those who want to volunteer in the Phase-3 study.
.
LET’S ACHIEVE THE RESULT TOGETHER
Health Minister, in a statement on his Twitter account, said the domestic vaccine was in the final stage, calling on citizens to volunteer for Phase-3. “Our domestic vaccine is in the final stage. Volunteer in the Phase 3 human study, let’s achieve the result together” with the message “The inactive Covid-19 Turkish vaccine developed in cooperation with Ministry of Health, Presidency of Turkish Institutes of Health, Kayseri Erciyes University and reached the final stage in the Phase 3 human study.
.
.
.